Ardent Health Partners, LLCARDTNYSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
3Y CAGR-8.5%
5Y CAGR+6.1%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-8.5%/yr
vs +11.2%/yr prior
5Y CAGR
+6.1%/yr
Recent deceleration
Acceleration
-19.7pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM7.94%-17.6%
20249.64%+48.9%
20236.47%-37.6%
202210.37%-4.2%
202110.82%+83.2%
20185.90%-23.2%
20177.69%+13.4%
20166.78%-35.6%
201510.54%-